Evidence map›Paper›PMID 29911202›Full record

ArticleCurrent opinion in biomedical engineering2018

Bio-chemo-mechanics of thoracic aortic aneurysms.

Jessica E Wagenseil

Open access · greenAbstract read
In one paragraph

Article in Current opinion in biomedical engineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of non-coding variants in cardiovascular disease.Journal of cellular and molecular medicine · 2023
    Review
  4. Experimental and Mouse-Specific Computational Models of the Fbln4Cardiovascular engineering and technology · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Central artery stiffness and thoracic aortopathy.American journal of physiology. Heart and circulatory physiology · 2019
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jessica E WagenseilDept. of Mechanical Engineering and Materials Science, Washington University, St. Louis, MO.
Washington University in St. Louis · US

Funding

VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIXR01HL105314 · NHLBI · WASHINGTON UNIVERSITY · PI MECHAM, ROBERT P., WAGENSEIL, JESSICA · 2010 to 2018
$3.2M
Loss of Matrix Regulation and Aortic Aneurysm Development in vivoR01HL106305 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI YANAGISAWA, HIROMI · 2011 to 2014
$1.5M
BIOMECHANICAL FACTORS IN CONGENITAL VASCULAR DISEASER01HL115560 · NHLBI · WASHINGTON UNIVERSITY · PI WAGENSEIL, JESSICA · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL105314NHLBI NIH HHS R01 HL106305NHLBI NIH HHS R01 HL115560
6 · The paper itself

Abstract

Most thoracic aortic aneurysms (TAAs) occur in the ascending aorta. This review focuses on the unique bio-chemo-mechanical environment that makes the ascending aorta susceptible to TAA. The environment includes solid mechanics, fluid mechanics, cell phenotype, and extracellular matrix composition. Advances in solid mechanics include quantification of biaxial deformation and complex failure behavior of the TAA wall. Advances in fluid mechanics include imaging and modeling of hemodynamics that may lead to TAA formation. For cell phenotype, studies demonstrate changes in cell contractility that may serve to sense mechanical changes and transduce chemical signals. Studies on matrix defects highlight the multi-factorial nature of the disease. We conclude that future work should integrate the effects of bio-chemo-mechanical factors for improved TAA treatment.

Identifiers

PMID29911202
PMCPMC5999324
OpenAlexW2792733854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.